UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000015373 |
|---|---|
| Receipt number | R000017890 |
| Scientific Title | Phase I/II study of clofarabine, etoposide and cyclophosphamide (CLEC) chemotherapy in adult patients with refractory or relapse acute lymphoblastic leukemia (JALSG RR-ALL214) |
| Date of disclosure of the study information | 2014/10/20 |
| Last modified on | 2020/03/14 19:21:54 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2014/10/08 15:54:35 | ||
| 2 | Update | 2015/07/30 09:07:06 | Recruitment status |
|
| 3 | Update | 2017/10/11 12:58:40 | Last name of contact person Last name of contact person Name of person sending information Name of person sending information Name of primary person or sponsor Organization Category of Funding Organization Email1 |
|
| 4 | Update | 2017/10/11 13:01:57 | Control |
|
| 5 | Update | 2020/03/11 09:54:47 | UMIN ID1 |
|
| 6 | Update | 2020/03/14 19:10:33 | Recruitment status Date of IRB Last follow-up date Date of closure to data entry |
|
| 7 | Update | 2020/03/14 19:21:54 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Organization Division name Zip code Address Address TEL Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
